|Articles|February 2, 2002

Early data points to Tx for recalcitrant conditions

Handful of agents promising for melanoma, AK, eczema, psoriasis

Newsletter

Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.


Latest CME